Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

NCT00086346 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

607

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Sirolimus (Rapamune)
DRUG: Cyclosporine or Tacrolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer